Amantadine Increases Gait Steadiness in Frontal Gait Disorder due to Subcortical Vascular Encephalopathy: A Double-Blind Randomized Placebo-Controlled Trial Based on Quantitative Gait Analysis

H. Baezner,M. Oster,O. Henning,S. Cohen,Michael G. Hennerici

Amantadine Increases Gait Steadiness in Frontal Gait Disorder due to Subcortical Vascular Encephalopathy: A Double-Blind Randomized Placebo-Controlled Trial Based on Quantitative Gait Analysis

2001

H. Baezner
M. Oster
O. Henning
S. Cohen
Michael G. Hennerici

In a randomized, double-blind placebo-controlled trial, 40 patients diagnosed as subcortical vascular encephalopathy (SVE) were given a daily dose of 500 ml i.v. amantadine vs. placebo for 5 days. Bot

Keywords:

Amantadine
Randomized controlled trial
Diabetes mellitus
Placebo
Gait
Gait analysis
Encephalopathy
Physical therapy
Placebo-controlled study
Medicine
double blind

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations